Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Roche Highlights Encouraging Data From Newly-Acquired Second Weight Loss Drug Candidate In Early-Stage Study
July 17, 2024
Tickers
NEWS
RHHBY
Tags
Eurasia
Equities
Large Cap
From
Benzinga
3 Small-Cap Stocks With Explosive 2X Growth Potential
July 08, 2024
Tickers
AMGN
BAYRY
CHPT
EXAI
Tags
VRDN
CHPT
RHHBY
From
InvestorPlace
Roche's New Immunotherapy Fails To Show Benefit Over Merck's Blockbuster Keytruda In Lung Cancer Patients
July 05, 2024
Tickers
MRK
NEWS
RHHBY
Tags
Large Cap
Biotech
Health Care
From
Benzinga
AbbVie/Genmab's Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway
June 27, 2024
Tickers
ABBV
BNTX
GMAB
JNJ
Tags
General
RHHBY
Briefs
From
Benzinga
Supreme Court Backs Pharmaceutical Giants in Iraq Terrorism Funding Case
June 24, 2024
Tickers
AZN
GEHC
JNJ
NEWS
Tags
AZN
Large Cap
Biotech
From
Benzinga
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
June 21, 2024
Tickers
AMGN
AZN
BMY
GILD
Tags
BMO Captial Markets
GILD
MRK
From
Benzinga
Sarepta Therapeutics (SRPT) Stock Surges 30% on Giant FDA Boost
June 21, 2024
Tickers
RHHBY
SRPT
Tags
RHHBY
Today's Market
SRPT
From
InvestorPlace
FDA Approves Expanded Use For Sarepta's Rare Muscular Dystrophy Gene Therapy
June 21, 2024
Tickers
NEWS
PFE
RGNX
RHHBY
Tags
Equities
SRPT
Biotech
From
Benzinga
Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside
June 07, 2024
Tickers
ABBV
FDMT
NEWS
REGN
Tags
Initiation
RGNX
Expert Ideas
From
Benzinga
Italy Probes European Pharma Giants Novartis, Roche Over Eye Drug Competition Allegations
June 06, 2024
Tickers
NEWS
NVS
RHHBY
Tags
NVS
Briefs
News
From
Benzinga
2 Cathie Wood Biotech Stocks That Could Be Worth the Risk
May 29, 2024
Tickers
ARKG
ARKK
DNA
RHHBY
Tags
ARKK
RXRX
Recent Press Releases
From
Motley Fool
If You'd Invested $100 in Viking Therapeutics Stock 2 Years Ago, Here's How Much You'd Have Today
May 26, 2024
Tickers
GS
RHHBY
VKTX
Tags
RHHBY
Recent Press Releases
VKTX
From
Motley Fool
Biden Administration Urges Supreme Court Review in Terrorism Funding Lawsuit Against Pharma Companies
May 23, 2024
Tickers
AZN
GEHC
JNJ
PFE
Tags
JNJ
Stories That Matter
General
From
Benzinga
This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan
May 21, 2024
Tickers
BHVN
GPCR
LLY
NEWS
Tags
Markets
RHHBY
News
From
Benzinga
Roche To Ride Booming Obesity Treatment Market With Newly-Acquired Drug Candidate
May 16, 2024
Tickers
NEWS
RHHBY
Tags
Stories That Matter
Market News
Top Stories
From
Benzinga
Can Ocugen Stock Keep Churning Higher?
April 29, 2024
Tickers
OCGN
RHHBY
VHT
Tags
RHHBY
Recent Press Releases
OCGN
From
Motley Fool
Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday?
April 24, 2024
Tickers
GILD
HOOK
NEWS
RHHBY
Tags
HOOK
Market News
GILD
From
Benzinga
2 Small-Cap Growth Stocks With Room To Run
April 24, 2024
Tickers
ACHR
OCUL
REGN
RHHBY
Tags
Market News
OCUL
RHHBY
From
Motley Fool
Roche's Lymphoma Drug With Chemo Extends Survival In Pretreated Patients
April 15, 2024
Tickers
HOOK
NEWS
RHHBY
RPTX
Tags
RPTX
Benzinga
Market News
From
Benzinga
Looking for an Easy Way to Earn Passive Income? This Vanguard ETF Pays a Dividend Yield of Nearly 4.9%.
April 14, 2024
Tickers
HSBC
NVS
RHHBY
SHEL
Tags
SHEL
Market News
RHHBY
From
Motley Fool
Why Roche Holdings Stock Popped Today
April 11, 2024
Tickers
LLY
RHHBY
Tags
RHHBY
Recent Press Releases
LLY
From
Motley Fool
Can Recursion Pharmaceuticals Stock Double in 5 Years? Here's What It Would Take.
April 10, 2024
Tickers
RHHBY
RXRX
Tags
Market News
RXRX
BAYR/Y
From
Motley Fool
Analysts Express Confidence in Alnylam's Hypertension Drug Despite Mixed Trial Data
April 08, 2024
Tickers
ALNY
NEWS
RHHBY
Tags
News
Briefs
RHHBY
From
Benzinga
Hot Stocks: The 3 Best Opportunities for Investing in Weight Loss Drugs
March 22, 2024
Tickers
LLY
REGN
RHHBY
Tags
NYSE:LLY,NASDAQ:REGN,OTCMKTS:RHHBY
RHHBY
REGN
From
InvestorPlace
Why Is European Pharma Giant Argenx Valued At Over $20B Trading Higher On Thursday?
March 21, 2024
Tickers
ARGX
JNJ
NEWS
RHHBY
Tags
RHHBY
General
why it's moving
From
Benzinga
Swiss Healthcare Manufacturing Firm Lonza Bolsters Biologics Manufacturing Capacity With Roche's US Facility Acquisition For $1.2B
March 20, 2024
Tickers
LZAGF
LZAGY
NEWS
RHHBY
Tags
Stories That Matter
LZAGY
News
From
Benzinga
FDA Approves BeiGene's First Drug Candidate Produced Through Its Immuno-Oncology Program For Esophageal Cancer
March 15, 2024
Tickers
BGNE
NEWS
NVS
RHHBY
Tags
BGNE
Stories That Matter
General
From
Benzinga
Top Wall Street Analysts Flag US Market Concentration Anxiety, Advise Investors To Adopt 'Barbell Approach'
March 11, 2024
Tickers
ASIA
ASML
AZN
GSK
Tags
AZN
Large Cap
Equities
From
Benzinga
FDA Conditionally Approves Expanded Use Of BeiGene's Combination Drug For Certain Type Of Blood Cancer
March 08, 2024
Tickers
ABBV
BGNE
GILD
NEWS
Tags
General
RHHBY
NVS
From
Benzinga
Roche/Alnylam Blood Pressure Drug Aces In Mid-Stage Trial, Analyst Says Zilebesiran As Promising Opportunity In Addressing Global Hypertension Challenges
March 05, 2024
Tickers
ALNY
NEWS
RHHBY
Tags
Expert Ideas
Analyst Color
Reiteration
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.